These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8960526)

  • 1. Evaluating the cost of therapy for restenosis: considerations for brachytherapy.
    Weintraub WS
    Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):949-58. PubMed ID: 8960526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and economic aspects of chronic coronary restenosis: potential advantage of intracoronary brachytherapy].
    Schiele TM; Siebert U; Cohen D; Klauss V
    Dtsch Med Wochenschr; 2001 Apr; 126(15):440-4. PubMed ID: 11347008
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic winners and losers after introduction of an effective new therapy depend on the type of payment system.
    Weintraub WS; Warner CD; Mauldin PD; Becker ER; Gomes D; Cook J; Kosinski A; Boccuzzi S
    Am J Manag Care; 1997 May; 3(5):743-9. PubMed ID: 10169536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endoluminal irradiation of coronary arteries: economic aspects before clinical safety?].
    Baer FM; Erdmann E
    Dtsch Med Wochenschr; 2001 Apr; 126(15):439. PubMed ID: 11347007
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model.
    Cohen DJ; Breall JA; Ho KK; Kuntz RE; Goldman L; Baim DS; Weinstein MC
    Circulation; 1994 Apr; 89(4):1859-74. PubMed ID: 8149551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of gamma radiation for treatment of in-stent restenosis: results from the Gamma-1 trial.
    Cohen DJ; Cosgrove RS; Berezin RH; Teirstein PS; Leon MB; Kuntz RE;
    Circulation; 2002 Aug; 106(6):691-7. PubMed ID: 12163429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restenosis: the cost to society.
    Califf RM
    Am Heart J; 1995 Sep; 130(3 Pt 2):680-4. PubMed ID: 7668217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical economic considerations of coronary stenting.
    Szucs TD
    Schweiz Med Wochenschr; 1999 Nov; 129(45):1701-11. PubMed ID: 10595380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracoronary radiotherapy (brachytherapy) for treatment of restenosis].
    Danchin N; Cottin Y
    Presse Med; 2001 May 5-12; 30(17):846-50. PubMed ID: 11402937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the expected costs of high dose rate brachytherapy using 252Cf versus 192Ir.
    Rivard MJ; Kirk BL; Stapleford LJ; Wazer DE
    Appl Radiat Isot; 2004 Dec; 61(6):1211-6. PubMed ID: 15388112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the cost of a clinical intervention through the use of shadow pricing.
    Ruchlin HS; Elkin EB; MacKenzie CR; Williams-Russo P; Allegrante JP
    Arthritis Care Res; 1997 Oct; 10(5):343-51. PubMed ID: 9362601
    [No Abstract]   [Full Text] [Related]  

  • 12. The ratio of costs to charges: how good a basis for estimating costs?
    Shwartz M; Young DW; Siegrist R
    Inquiry; 1995-1996 Winter; 32(4):476-81. PubMed ID: 8567084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allocating global package pricing. The example of bypass surgery.
    Biebuyck JF; Locke J
    Med Group Manage J; 1996; 43(1):16, 18, 20-4. PubMed ID: 10154118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery.
    Cohen DJ; Breall JA; Ho KK; Weintraub RM; Kuntz RE; Weinstein MC; Baim DS
    J Am Coll Cardiol; 1993 Oct; 22(4):1052-9. PubMed ID: 8409040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
    Laviana AA; Ilg AM; Veruttipong D; Tan HJ; Burke MA; Niedzwiecki DR; Kupelian PA; King CR; Steinberg ML; Kundavaram CR; Kamrava M; Kaplan AL; Moriarity AK; Hsu W; Margolis DJ; Hu JC; Saigal CS
    Cancer; 2016 Feb; 122(3):447-55. PubMed ID: 26524087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary effects of brachytherapy in the treatment of coronary restenosis].
    Cottin Y; Zeller M; Allouch P; Maingon P; Barillot I; Busseuil D; Naudy S; Horiot JC; Rochette L; Wolf JE
    Arch Mal Coeur Vaiss; 2001 Mar; 94(3):218-22. PubMed ID: 11338257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular radiation therapy to reduce coronary artery restenosis.
    Chougule PB
    Surg Oncol Clin N Am; 2000 Jul; 9(3):577-84, x. PubMed ID: 10853143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary brachytherapy: an evolving modality for treatment of restenosis following percutaneous coronary intervention.
    Srinivas VS; Williams DO; Chougale P; Shearer D
    Med Health R I; 2001 Feb; 84(2):51-4. PubMed ID: 11272660
    [No Abstract]   [Full Text] [Related]  

  • 19. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators.
    Cohen DJ; Krumholz HM; Sukin CA; Ho KK; Siegrist RB; Cleman M; Heuser RR; Brinker JA; Moses JW; Savage MP
    Circulation; 1995 Nov; 92(9):2480-7. PubMed ID: 7586348
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.